Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1117 ARTÍCULOS , VIENDO DEL 181 AL 195

Design, current states, and challenges of nanomaterials in anti-neuroinflammation: A perspective on Alzheimer's disease

Hong X, Chen T, Liu Y, Li J, Huang D, Ye K, Liao W, Wang Y, Liu M, Luan P.

Ageing Res Rev. 2025 Mar;105:102669. doi: 10.1016/j.arr.2025.102669. Epub 2025 Jan 27.

Sleep-wake modulation and pathogenesis of Alzheimer disease: Suggestions for postponement and treatment

Liu YJ, Swaab DF, Zhou JN.

Handb Clin Neurol. 2025;206:211-229. doi: 10.1016/B978-0-323-90918-1.00001-0.

Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies

Wang S, Liao Z, Zhang Q, Han X, Liu C, Wang J.

Front Immunol. 2025 Jan 14;15:1484373. doi: 10.3389/fimmu.2024.1484373. eCollection 2024.

Uncovering the intricacies of IGF-1 in Alzheimer's disease: new insights from regulation to therapeutic targeting

Kaur N, Aran KR.

Inflammopharmacology. 2025 Mar;33(3):1311-1330. doi: 10.1007/s10787-025-01641-0. Epub 2025 Jan 30.

Melatonin Overexpression in the Management of Alzheimer's Disease: Therapeutic Exploration

Gupta B, Malviya R, Sundram S, Sridhar SB, Singh DP.

Curr Top Med Chem. 2025;25(15):1783-1794. doi: 10.2174/0115680266327614241121050448.

Massive changes in gene expression and their cause(s) can be a unifying principle in the pathobiology of Alzheimer's disease

Coleman PD, Delvaux E, Kordower JH, Boehringer A, Huseby CJ.

Alzheimers Dement. 2025 Feb;21(2):e14555. doi: 10.1002/alz.14555. Epub 2025 Feb 6.

Understanding of Alzheimer's disease pathophysiology for therapeutic implications of natural products as neuroprotective agents

Prabha S, Choudhury A, Islam A, Thakur SC, Hassan MI.

Ageing Res Rev. 2025 Mar;105:102680. doi: 10.1016/j.arr.2025.102680. Epub 2025 Feb 6.

Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer's Disease

Lee E, Chang Y.

Cells. 2025 Jan 22;14(3):168. doi: 10.3390/cells14030168.

Beyond plaques and tangles: The role of immune cell dysfunction in Alzheimer's disease

Hussain N, Khan MM, Sharma A, Singh RK, Khan RH.

Neurochem Int. 2025 Mar;184:105947. doi: 10.1016/j.neuint.2025.105947. Epub 2025 Feb 14.

Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer's Disease

Priyadarshini S, Goyal K, R R, Gupta S, Roy A, Biswas R, Patra S, Chauhan P, Wadhwa K, Singh G, Kamal M, Iqbal D, Alsaweed M, Nuli MV, Abomughaid MM, Almutary AG, Sinha JK, Bansal P, Rani B, Walia C, Sivaprasad GV, Ojha S, Nelson VK, Jha NK.

Mol Neurobiol. 2025 Jul;62(7):8166-8186. doi: 10.1007/s12035-024-04484-y. Epub 2025 Feb 21.

Peripheral and central neuroimmune mechanisms in Alzheimer's disease pathogenesis

Zhang S, Gao Y, Zhao Y, Huang TY, Zheng Q, Wang X.

Mol Neurodegener. 2025 Feb 21;20(1):22. doi: 10.1186/s13024-025-00812-5.

Role of tau versus TDP-43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

Wisse LEM, Wuestefeld A, Murray ME, Jagust W, La Joie R.

Alzheimers Dement. 2025 Feb;21(2):e14582. doi: 10.1002/alz.14582.

Disrupted astrocyte-neuron signaling reshapes brain activity in epilepsy and Alzheimer's disease

Wu M, Zhang R, Fu P, Mei Y.

Neuroscience. 2025 Mar 27;570:132-151. doi: 10.1016/j.neuroscience.2025.02.029. Epub 2025 Feb 20.

Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer's Disease

Rahmatkar SN, Singh D.

Mol Neurobiol. 2025 Jul;62(7):8603-8623. doi: 10.1007/s12035-025-04776-x. Epub 2025 Feb 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias